2025³â 08¿ù 06ÀÏ ¼ö¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92490°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

ÇÑÈ­»ý¸í, ¹Ì±¹ Áõ±Ç»ç º§·Î½ÃƼ Àμö ¿Ï·á

ºÏ¹Ì ÀÚº» ½ÃÀåÀ¸·ÎÀÇ Àü·«Àû È®Àå
ÇÑÈ­»ý¸íÀº ¹Ì±¹ Áõ±Ç»ç ‘º§·Î½ÃƼ’ÀÇ ÁöºÐ 75% Àμö ÀýÂ÷¸¦ 30ÀÏ(ÇöÁö½Ã°£) ¼º°øÀûÀ¸·Î ¸¶¹«¸®Çϰí, º¸Çè Áß½ÉÀÇ Æ÷Æ®Æú¸®¿À¸¦ ³Ñ¾î ºÏ¹Ì ÀÚº» ½ÃÀåÀ¸·ÎÀÇ Àü·«Àû È®ÀåÀ» º»°ÝÈ­ÇÑ´Ù°í 31ÀÏ ¹àÇû´Ù. À̹ø º§·Î½ÃƼ Àμö´Â ±¹³» º¸Çè»ç°¡ ‘±Û·Î¹ú ÀÚº» ½ÃÀåÀÇ Á߽ɺΒÀÎ ¹Ì±¹ Áõ±Ç ½ÃÀå¿¡ ÁøÃâÇÑ ÃÖÃÊÀÇ »ç·Ê´Ù. À̷νá ÇÑÈ­»ý¸íÀº ¹Ì±¹ ÇöÁö ±ÝÀ¶»ç¸¦ ÅëÇØ ¼öÀͼºÀ» ³ôÀ̰í, ¿ì¼öÇÑ ±Û·Î¹ú ±ÝÀ¶ »óǰÀ» ±Û·Î¹ú °í°´¿¡°Ô Á¦°øÇÒ ¼ö ÀÖ´Â Ç÷§ÆûÀ» ¸¶·ÃÇß´Ù. ´º¿åÀ» °ÅÁ¡À¸·Î ÇÑ º§·Î½ÃƼ´Â ±ÝÀ¶ °Å·¡ ü°á ...
MultiBank Group Secures a European CySEC Broker License, Bec... (2023-07-20)
Çö´ëÀÚµ¿Â÷ ¿ùµå·¤¸®ÆÀ, 2024 WRC ½º¿þµ§ ·¤¸® ¿ì½Â (2024-02-19)
¸®°ÉÅ×Å© Çõ½ÅÀ» ¸¸³ª´Â 'ÄÚ¸®¾Æ ¸®°É-Å×Å© Æ÷·³ 2024' (2024-05-25)
ÇÁ·Îµà¼­, Àۻ簡, ÀÛ°î°¡ ¹Ú¹Î¼ö ÀÎÅͺä (2023-10-13)
Xsolla and Savvy Games Group Sign Memorandum of Understandin... (2024-08-29)
Diverse Egypt: An award-winning and safe travel destination ... (2023-12-15)
½ÅÇÑÄ«µå, 'Æ÷ÀÎÆ® Ç÷£' Ãâ½Ã... 3%+ Æ÷ÀÎÆ® Àû¸³ (2024-03-20)
°ÕÁ¶, ȯ»óÀûÀÎ Á¤±ÛºÏ ÆË¾÷ Ä«Æä ¿ÀÇ (2016-04-29)
Àå¾Ö¿¹¼úÀÎÀÓ Áõ¸íÇÒ ¼ö ÀÖ´Â µî·Ï ½Ã½ºÅÛ ÇÊ¿ä (2024-02-16)
Çìºñ¸ÞÅ» ¸íǰ¹êµå ¡®ºí·¢È¦¡¯ ¼ö¿ø Äܼ­Æ® °³ÃÖ (2024-02-16)
SOVAC, ÅõÀÚÀ¯Ä¡¡¤°í°´ È®º¸¡¤ÆÇ·Î°³Ã´ µî °í¹Î ÇØ°á»ç (2023-09-29)
DigiLens Expands Technology Ecosystem with Leading Electroni... (2024-02-05)
'µ¶¹ÚÅõ¾î¡¯ µ¶¹ÚÁî, ½É¾ß ¿ìµ¿ ½Ä´ç¼­ ¸éÄ¡±â µ¥½Ãº§ ´ë°á (2024-05-11)
Kinaxis Provides Business Update (2024-09-28)
´ëÇÑÇ×°ø, ±âÇÁƮīµå ¼­ºñ½º Ãâ½Ã (2023-10-18)
½ÅÈ¥ °¡Àü Å©±â°¡ ±Ã±ÝÇÒ ¶§ ±ò¾Æº¸¼¼¿ä (2023-10-07)
¾Ð±¸Á¤ ¸ÀÁýµé°ú ¡®½Ì±ÛÅæ µô¸®¼Å½º µð½ºÄ¿¹ö¸®½º¡¯ Ä·ÆäÀÎ (2023-09-04)
ECONINE, Top 5% in EcoVadis Global ¡®ESG Assessment¡¯ (2023-01-30)
µ¿¾Æ¹æ¼Û¿¹¼ú´ë, ¼¼Á¾¹®È­È¸°ü°ú ¹®È­¿¹¼ú Àúº¯ È®´ë Çù¾à (2024-05-19)
ºÎ¸ð´Ô¿¡°Ô ²À ÇØµå¸®°í ½ÍÀº 39°¡Áö (2016-11-10)
Àå³â ä¿ë ¾Ë¹Ù °ø°í ¡®6³â»õ 6¹è¡¯ Áõ°¡ (2017-09-30)
¿¹¼ú±³À°°ú ÇÔ²² °ø¿¬¹°Ç°ÀÇ °øÀ¯¹®È­ È®»ê (2024-03-25)
Vestel Joins HEVC Advance Patent Pool (2024-03-14)
´Ù¾çÇÑ ¿µÇâÀ» ÁÖ°í ¹ÞÀº Ç×°ø±â, ¼±¹Ú, ÀÚµ¿Â÷ (2016-09-21)
ºÎ¹Ö½ºÆ©µð¿À½º, ½ÇÇèÀ½¾ÇÀ» Àü¹®À¸·Î ÇÏ´Â °ø¿¬ °³ÃÖ (2024-01-30)
       [ÀÌÀü][1]....[753][754][755][756][757][758][759][760][761]...[3700][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..